Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-09-25
This study evaluates moesin (MSN) as a circulating indicator of endothelial injury in sepsis and connects its elevation with ROCK1/MLC and NF-κB signaling. Human observations, mouse models, and endothelial-cell experiments provide converging evidence, while leaving clinical diagnostic performance and causality in patients to be established.
-
DiscoveryProbe™: Designing Better Stem Cell Screens
2026-09-25
DiscoveryProbe Stem Cell Compound Library Plus can help researchers move beyond hit lists to interpretable stem cell pathway profiles. This guide focuses on assay design, evidence strength, and the limits of translating a parasite neoblast screen into other stem cell systems.
-
Quercetin Beyond PI3K: Interpreting Ferroptosis Evidence
2026-09-24
Quercetin is often studied as a PI3K inhibitor, but Wilson’s disease models reveal a distinct research angle: testing how ferroptosis, lipid remodeling, and target engagement fit together. This article turns that evidence into practical assay-selection guidance while distinguishing preclinical findings from established therapeutic claims.
-
SFRP1, Neutrophils, and Wnt Signaling in Oral Fibrosis
2026-09-24
An arecoline-induced model study links reduced SFRP1 with increased neutrophil infiltration, Wnt/β-catenin pathway activity, and oral submucous fibrosis. SFRP1 overexpression attenuated inflammatory and fibrotic features, while pathway activation counteracted these effects, supporting a mechanistic connection that warrants further testing.
-
Protease Inhibitor Cocktail EDTA-Free for Biomarkers
2026-09-24
Learn how a Protease Inhibitor Cocktail EDTA-Free can help preserve protein readouts in therapeutic biomarker studies. This article connects a recent melatonin-hydrogel study to practical sample-preparation decisions while clarifying what protease inhibitors can—and cannot—tell you.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-23
5X Protein Loading Buffer (Reducing) standardizes reducing protein sample preparation for conventional SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and tracking dye. It is intended for denaturing molecular-weight separation and should not be used when native structure, disulfide-dependent complexes, or non-reducing conditions must be preserved.
-
Naked Mole-Rat cGAS Rewrites DNA Repair and Aging
2026-09-22
A 2025 Science study identifies an evolutionary reversal in naked mole-rat cGAS: four amino acid substitutions convert it from a suppressor of homologous recombination into a promoter of DNA repair. The work connects altered cGAS ubiquitination, prolonged chromatin retention, FANCI–RAD50 recruitment, reduced senescence, and improved aging phenotypes across cellular and animal models.
-
BCA Protein Quantification Kit K4102
2026-09-22
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports low-concentration total protein measurement in samples such as dilute biochemical preparations and cell lysates. It is intended for research workflows, including sample normalization, and must not be used for diagnostic, clinical, or medical testing.
-
U0126-EtOH: MEK1/2 Strategy for Translation
2026-09-21
A mechanistic and translational framework for using U0126-EtOH to dissect MEK1/2–ERK1/2 signaling across neuronal injury, inflammation, and differentiation models while avoiding overinterpretation of pathway-selective data.
-
CHIR-99021 and the Next Generation of Human Neuron Models
2026-09-21
CHIR-99021 (CT99021) offers a mechanistically precise way to tune GSK-3 and Wnt/β-catenin biology in stem-cell workflows. This thought-leadership analysis connects that capability to the qualification of human iPSC-derived sensory neurons for studying HSV-1 latency, while separating validated evidence from forward-looking experimental strategy.
-
Novel PRRSV-1 GD2022: Genome and Pathogenicity
2026-09-20
A 2024 Frontiers in Microbiology study isolated GD2022, a distinct PRRSV-1 subtype 1 strain from southern China, and combined cell culture, molecular, genomic, and animal evidence to characterize it. The findings establish GD2022 as a pathogenic reference isolate while highlighting genomic divergence in antigenic regions and the need for orthogonal confirmation in PRRSV surveillance.
-
Z-WEHD-FMK for Caspase-1 Pathway Studies
2026-09-19
Z-WEHD-FMK provides a cell-permeable, irreversible way to test whether inflammatory caspase activity drives pyroptosis, pathogen-associated remodeling, or related cell-death phenotypes. This article translates recent HOXC8–caspase-1 findings into practical workflows for inflammation research, infectious disease research, and apoptosis assay design.
-
Protease Inhibitor Cocktail EDTA-Free: Practical Guide
2026-09-19
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during cell lysis, protein extraction, and sample preparation. It is suited to workflows where EDTA could disrupt divalent-cation-dependent assays, but it should not be treated as a phosphatase inhibitor, fixative, or universal solution for every source of sample degradation.
-
Tunable Human Intestinal Organoids: Study Insights
2026-09-18
Yang and colleagues developed a human small intestinal organoid system that maintains high proliferation while increasing cellular diversity through coordinated small-molecule control of stemness and differentiation. The work provides a scalable framework for studying intestinal biology and for designing organoid workflows in which cell fate can be shifted without recreating complex spatial signaling gradients.
-
LDH Cytotoxicity Assay Kit for Nanomaterial Safety
2026-09-17
Translate membrane damage into a quantitative, non-radioactive endpoint for nanomaterial screening, cancer research, and disease-model studies. The LDH Cytotoxicity Assay Kit pairs a practical 490 nm readout with controls that help distinguish genuine toxicity from interference caused by magnetite-containing formulations.